Skip to main content
HRES 1154 115th Congress House Health Business investment and capital Congressional tributes Drug safety, medical device, and laboratory regulation Drug therapy Health care quality Health promotion and preventive care Medical research Research and development

Affirming the importance of the Orphan Drug Act, applauding its lifesaving contributions over its 35-year history, and recognizing the need to continue supporting research and development for rare…

Show full title

Affirming the importance of the Orphan Drug Act, applauding its lifesaving contributions over its 35-year history, and recognizing the need to continue supporting research and development for rare diseases.

Introduced: November 16, 2018 See on congress.gov
This resolution expired with the 115th Congress
It was not agreed to before the 115th Congress (2017–2018) adjourned, so it is no longer active. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Agreed to (House)
Nov 16, 2018
Referred to the House Committee on Energy and Commerce.
Nov 16, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Applauds the growth in research and development into new therapies for rare diseases and the resulting number of FDA-approved therapies for those living with rare diseases, and affirms the need to continue supporting such research and development.

Recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure thousands of rare diseases for which no treatment options are currently available.

What's happening now November 16, 2018

Referred to the House Committee on Energy and Commerce.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H. Res. 1154: Affirming the importance of the Orphan Drug Act, applauding its lifesaving contributions over its 35-year history, and recognizing the need to continue supporting research and development for rare diseases.. 115th Congress. Open America. https://openamerica.io/bill/115-HRES-1154/
MLA
"H. Res. 1154: Affirming the importance of the Orphan Drug Act, applauding its lifesaving contributions over its 35-year history, and recognizing the need to continue supporting research and development for rare diseases.." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HRES-1154/.
Bluebook (legal)
H. Res. 1154, 115th Cong. (2026), https://openamerica.io/bill/115-HRES-1154/.
Markdown link
[H. Res. 1154: Affirming the importance of the Orphan Drug Act, applauding its lifesaving contributions over its 35-year history, and recognizing the need to continue supporting research and development for rare diseases.](https://openamerica.io/bill/115-HRES-1154/)
Report a problem